πŸ‡ΊπŸ‡Έ FDA
Patent

US 8197818

EML4-ALK fusion gene

granted A61KA61K31/506A61P

Quick answer

US patent 8197818 (EML4-ALK fusion gene) held by CUREGENE K.K. expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CUREGENE K.K.
Grant date
Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K31/506, A61P, A61P35/00, A61P43/00